Properties
Description
DC_AC50 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases.
Molecular Formula
C17H12BrF2N3OS
Identity
Confirmed by NMR/HPLC/MS.
Applications
DC_AC50 is utilized to understand the inhibition of matrix metalloproteinases, aiming at preventing tissue degradation involved in cancer progression and other diseases.